PT2784157T - Método para conceber proteínas de ligação a rna usando o motivo ppr e sua utilização - Google Patents

Método para conceber proteínas de ligação a rna usando o motivo ppr e sua utilização

Info

Publication number
PT2784157T
PT2784157T PT128414356T PT12841435T PT2784157T PT 2784157 T PT2784157 T PT 2784157T PT 128414356 T PT128414356 T PT 128414356T PT 12841435 T PT12841435 T PT 12841435T PT 2784157 T PT2784157 T PT 2784157T
Authority
PT
Portugal
Prior art keywords
ppr
reason
binding proteins
designing rna
rna
Prior art date
Application number
PT128414356T
Other languages
English (en)
Portuguese (pt)
Inventor
Nakamura Takahiro
Yagi Yusuke
Kobayashi Keiko
Original Assignee
Univ Kyushu Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyushu Nat Univ Corp filed Critical Univ Kyushu Nat Univ Corp
Publication of PT2784157T publication Critical patent/PT2784157T/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289—Male sterility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/30—Detection of binding sites or motifs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/85—Fusion polypeptide containing an RNA binding domain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10—Nucleic acid binding proteins
    • C12Q2522/101—Single or double stranded nucleic acid binding proteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Library & Information Science (AREA)
  • Computing Systems (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
PT128414356T 2011-10-21 2012-10-22 Método para conceber proteínas de ligação a rna usando o motivo ppr e sua utilização PT2784157T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011231346 2011-10-21

Publications (1)

Publication Number Publication Date
PT2784157T true PT2784157T (pt) 2019-10-29

Family

ID=48141047

Family Applications (1)

Application Number Title Priority Date Filing Date
PT128414356T PT2784157T (pt) 2011-10-21 2012-10-22 Método para conceber proteínas de ligação a rna usando o motivo ppr e sua utilização

Country Status (8)

Country Link
US (7) US9513283B2 (cg-RX-API-DMAC10.html)
EP (2) EP2784157B1 (cg-RX-API-DMAC10.html)
JP (9) JP6164488B2 (cg-RX-API-DMAC10.html)
AU (5) AU2012326971C1 (cg-RX-API-DMAC10.html)
DK (1) DK2784157T3 (cg-RX-API-DMAC10.html)
ES (1) ES2751126T3 (cg-RX-API-DMAC10.html)
PT (1) PT2784157T (cg-RX-API-DMAC10.html)
WO (1) WO2013058404A1 (cg-RX-API-DMAC10.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2751126T3 (es) 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
WO2013155555A1 (en) * 2012-04-16 2013-10-24 The University Of Western Australia Peptides for the binding of nucleotide targets
KR20160007541A (ko) * 2013-04-22 2016-01-20 고쿠리쓰다이가쿠호진 규슈다이가쿠 피피알 모티프를 이용한 디앤에이 결합성 단백질 및 그의 이용
EP3613854A1 (en) 2014-03-05 2020-02-26 National University Corporation Kobe University Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
JP6664693B2 (ja) 2015-09-09 2020-03-13 国立大学法人神戸大学 標的化したdna配列の核酸塩基を特異的に変換する、グラム陽性菌のゲノム配列の変換方法、及びそれに用いる分子複合体
AU2016359629B2 (en) 2015-11-23 2023-03-09 Ranjan BATRA Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/Cas9
CN108495932B (zh) 2015-11-27 2022-08-09 国立大学法人神户大学 用于特异性转换靶向dna序列的核酸碱基的单子叶植物的基因组序列的转换方法、及其使用的分子复合体
WO2017209122A1 (ja) 2016-06-03 2017-12-07 国立大学法人九州大学 標的mRNAからのタンパク質発現量を向上させるための融合タンパク質
ES2874230T3 (es) * 2016-06-03 2021-11-04 Univ Kyushu Nat Univ Corp Proteína de fusión para mejorar la expresión de proteínas a partir de ARNm diana
JPWO2018030488A1 (ja) * 2016-08-10 2019-06-13 富士フイルム和光純薬株式会社 Pprモチーフを利用したdna結合性タンパク質およびその利用
WO2018208998A1 (en) 2017-05-10 2018-11-15 The Regents Of The University Of California Directed editing of cellular rna via nuclear delivery of crispr/cas9
CN108959852B (zh) * 2017-05-24 2021-12-24 北京工业大学 基于氨基酸-核苷酸成对偏好性信息的蛋白质上与rna结合模块的预测方法
CN108932400B (zh) * 2017-05-24 2021-07-23 北京工业大学 一种考虑界面信息的有效的蛋白质-rna复合物结构预测方法
CN112930395A (zh) 2018-06-08 2021-06-08 洛卡纳生物股份有限公司 靶向rna的融合蛋白组合物和使用方法
US12637682B2 (en) 2019-04-16 2026-05-26 The Regents Of The University Of California Protein translational control
US12559528B2 (en) * 2019-05-29 2026-02-24 Editforce, Inc. PPR protein causing less aggregation and use of the same
CN114729017A (zh) 2019-05-29 2022-07-08 日商基因编辑力股份有限公司 Ppr蛋白的有效制作方法及其应用
JP2022540446A (ja) 2019-07-10 2022-09-15 ロックアネイビオ, インコーポレイテッド Rna標的ノックダウン及び置換の組成物及び使用方法
IL296955A (en) 2020-03-31 2022-12-01 Editforce Inc Method for editing target rna
US20240000972A1 (en) 2020-12-01 2024-01-04 Locanabio, Inc. Rna-targeting compositions and methods for treating cag repeat diseases
WO2022119979A1 (en) 2020-12-01 2022-06-09 Locanabio, Inc. Rna-targeting compositions and methods for treating myotonic dystrophy type 1
WO2022221278A1 (en) 2021-04-12 2022-10-20 Locanabio, Inc. Compositions and methods comprising hybrid promoters
CA3216419A1 (en) 2021-04-23 2022-10-27 Greg NACHTRAB Tissue-targeted modified aav capsids and methods of use thereof
WO2022226375A1 (en) 2021-04-23 2022-10-27 Locanabio, Inc. Tissue-targeted modified aav capsids and methods of use thereof
US20250281571A1 (en) * 2021-04-30 2025-09-11 Osaka University Therapeutic drug for myotonic dystrophy type 1
JP7125727B1 (ja) * 2021-09-07 2022-08-25 国立大学法人千葉大学 核酸配列改変用組成物および核酸配列の標的部位を改変する方法
WO2023050204A1 (zh) * 2021-09-29 2023-04-06 京东方科技集团股份有限公司 Rna-蛋白质相互作用预测方法、装置、介质及电子设备
WO2023120658A1 (ja) * 2021-12-24 2023-06-29 国立大学法人北陸先端科学技術大学院大学 酵素、複合体、組換えベクター、遺伝性疾患治療薬及びポリヌクレオチド
WO2023154807A2 (en) 2022-02-09 2023-08-17 Locanabio, Inc. Compositions and methods for modulating pre-mrna splicing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040117868A1 (en) 2002-01-29 2004-06-17 Jun Imamura Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same
JP4102099B2 (ja) 2001-04-25 2008-06-18 アンスティテュ ナシオナル ドゥ ラ ルシェルシュ アグロノミック 細胞質雄性不稔から可稔への回復に関与するタンパク質及びそれをコードする遺伝子
AU2002251533B2 (en) 2001-04-25 2006-09-28 Institut National De La Recherche Agronomique Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene
JP2002355041A (ja) * 2001-04-25 2002-12-10 Mitsubishi Chemicals Corp 細胞質雄性不稔から可稔への回復に関与する遺伝子
US20060041961A1 (en) * 2004-03-25 2006-02-23 Abad Mark S Genes and uses for pant improvement
JP5713314B2 (ja) 2008-03-12 2015-05-07 国立大学法人東北大学 イネcw型雄性不稔細胞質に対する稔性回復遺伝子及び稔性回復方法
PT2816112T (pt) 2009-12-10 2018-11-20 Univ Iowa State Res Found Inc Modificação do adn modificada pelo efector tal
JP2013128413A (ja) 2010-03-11 2013-07-04 Kyushu Univ Pprモチーフを利用したrna結合性蛋白質の改変方法
ES2751126T3 (es) * 2011-10-21 2020-03-30 Univ Kyushu Nat Univ Corp Método de diseño para proteína de unión a ARN usando motivo de PPR, y uso del mismo
WO2013155555A1 (en) * 2012-04-16 2013-10-24 The University Of Western Australia Peptides for the binding of nucleotide targets

Also Published As

Publication number Publication date
AU2012326971B2 (en) 2017-10-19
WO2013058404A1 (ja) 2013-04-25
JPWO2013058404A1 (ja) 2015-04-02
AU2012326971A1 (en) 2014-06-12
US9513283B2 (en) 2016-12-06
US20200294626A1 (en) 2020-09-17
US20140335521A1 (en) 2014-11-13
US10679731B2 (en) 2020-06-09
US10943671B2 (en) 2021-03-09
AU2022204654A1 (en) 2022-07-21
JP2018042569A (ja) 2018-03-22
JP7590019B2 (ja) 2024-11-26
US10340028B2 (en) 2019-07-02
JP6454398B2 (ja) 2019-01-16
US20210249103A1 (en) 2021-08-12
AU2019280013B2 (en) 2022-03-31
US20170124252A1 (en) 2017-05-04
JP6270192B2 (ja) 2018-01-31
AU2017254874B2 (en) 2019-09-12
JP6267388B2 (ja) 2018-01-24
ES2751126T3 (es) 2020-03-30
US20260134942A9 (en) 2026-05-14
AU2022204654B2 (en) 2025-04-03
US20240047005A1 (en) 2024-02-08
AU2012326971C1 (en) 2018-02-08
JP2021130678A (ja) 2021-09-09
US20190311783A1 (en) 2019-10-10
EP3611261B1 (en) 2026-06-24
JP2017148078A (ja) 2017-08-31
DK2784157T3 (da) 2019-10-21
US20180247018A1 (en) 2018-08-30
JP2024010112A (ja) 2024-01-23
EP2784157B1 (en) 2019-09-18
JP2017192391A (ja) 2017-10-26
EP2784157A4 (en) 2015-07-01
JP7157483B2 (ja) 2022-10-20
AU2017254874A1 (en) 2017-11-16
JP6934644B2 (ja) 2021-09-15
US12646586B2 (en) 2026-06-02
AU2019280013A1 (en) 2020-01-16
JP2025020327A (ja) 2025-02-12
JP2018078896A (ja) 2018-05-24
JP7381133B2 (ja) 2023-11-15
JP7789426B2 (ja) 2025-12-22
US11742056B2 (en) 2023-08-29
EP3611261A1 (en) 2020-02-19
JP6164488B2 (ja) 2017-07-19
AU2025204996A1 (en) 2025-07-24
EP3611261C0 (en) 2026-06-24
EP2784157A1 (en) 2014-10-01
US9984202B2 (en) 2018-05-29
JP2022177289A (ja) 2022-11-30

Similar Documents

Publication Publication Date Title
IL288203B (en) Meditopes and meditope-binding antibodies and uses thereof
PT2427212T (pt) Anticorpos anti-cd100 e métodos para utilização dos mesmos
DK2784157T3 (da) Designfremgangsmåde til et rna-bindende protein under anvendelse af ppr-motiv og anvendelse deraf
PT2726092T (pt) Polipéptidos de fusão serpina e métodos para a sua utilização
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
BR112014018566A2 (pt) artigo de fundo de poço seletivamente corrosível e método para sua remoção
BRPI1008740A2 (pt) Proteínas pesticidas e métodos para seu uso.
BR112014000735A2 (pt) genes e proteína para a síntese de alcanoil-coa
ME03605B (me) Inhibitori virusne replikacije
CO6920293A2 (es) Compuestos antibaterianos y método para su uso
EP2707031A4 (en) ACTIVE PROTEIN-PRINCIPLE CONJUGATES AND PREPARATION METHOD THEREOF
BR112014005744A2 (pt) composições de peptídeo glucagon-like-2 e métodos para sua produção e utilização
BR112014007789A2 (pt) sistemas e métodos para análise biológica
DK2794654T3 (da) Anti-phf-tau-antistoffer og deres anvendelser
BR112013030381A2 (pt) reagentes e métodos para tratar doença dental
BRPI1012638A2 (pt) métodos e intermediários para preparar agentes farmacêuticos
BR112013019076A2 (pt) conjunto de peneira e um método para a respectiva construção
PT2858490T (pt) Elementos de adn recombinantes para a expressão de proteínas recombinantes em insetos
BR112013006131A2 (pt) inibidores de notum pectinacetilesterase e métodos para sua utilização
DK2721152T3 (da) Dimere bindingsproteiner baseret på modificerede ubiquitiner
DK3173102T3 (da) FGFR-FC-fusionsprotein og anvendelse deraf
PT2718434T (pt) Composições e métodos para tratar a doença de espru celíaco
BR112014028294A2 (pt) estrutura flutuante e método para a sua obtenção
BR112013028894A2 (pt) composto de tiazol, métodos para preparação e uso do mesmo
BR112015002609A2 (pt) carbamatos, processo para sua preparação e seu uso